Biotechnology Research
San Francisco, California
2-10 employees
Founded 2019
About Altay Therapeutics
Altay Therapeutics is a biotechnology company focused on unlocking the therapeutic potential of transcription factor inhibition for serious, underserved diseases. It develops highly-selective small-molecule inhibitors and operates a drug discovery platform to create first- or best-in-class treatments. The company's pipeline targets patients with limited options in areas such as muscular dystrophy, cancer, and inflammatory diseases.
Company Classification
Customer Types
B2B
Business Models
ProductsLicensing
Product & Service Types
Small-molecule therapeutic drugsDrug discovery platform
Customers
| Customer | Success Story | Source |
|---|---|---|
| Awarded Altay Therapeutics a Golden Ticket award. | ||
| Awarded Altay Therapeutics a Golden Ticket. | ||
Nice Try Sign up to Ethos to access the full customer list Sign up to Ethos | Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. | Source |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos